DNTH latest filing

Recent Insider Trading Activity Dianthus Therapeutics, Inc. /DE/ (DNTH) Recent Insider Trading Activity From Our SEC Form 4 Tracker

Ticker Filing Date Company Insider Title Transaction Shares Price Total Value Position Size Change SEC Filing
DNTH 2026-08-19 Dianthus Therapeutics, Inc. /DE/ Read Simon Director Sell 2,778 $117.55 $326,553.90 100.00% View Filing
DNTH 2026-08-11 Dianthus Therapeutics, Inc. /DE/ McGeorge Anne Director Sell 7,750 $109.01 $844,822.00 38.85% View Filing
DNTH 2026-08-11 Dianthus Therapeutics, Inc. /DE/ Read Simon Director Sell 2,777 $109.55 $304,231.75 28.17% View Filing
DNTH 2026-08-11 Dianthus Therapeutics, Inc. /DE/ Veness Adam M SVP, General Counsel and Sec. Sell 16,167 $110.38 $1,784,513.46 100.00% View Filing
DNTH 2026-08-11 Dianthus Therapeutics, Inc. /DE/ Veness Adam M SVP, General Counsel and Sec. Sell 3,833 $110.70 $424,319.25 86.15% View Filing

Real-time employee trading alerts from SEC Form 4 filings.

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and direct SEC filing links
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.84 seconds
  • Alert intervals starting from one minute
  • Filter alerts by ticker
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.